Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
After entering the muscle cell, glucose is immediately and irreversibly phosphorylated to glucose-6-phosphate by hexokinases (HK) I and II. Previous studies in rodents have shown that HKII may be the dominant HK in skeletal muscle. Reduced insulin-stimulated glucose uptake and reduced glucose-6-phosphate concentrations in muscle have been found in non-insulin-dependent diabetes mellitus (NIDDM) patients when examined during a hyperglycemic hyperinsulinemic clamp. These findings [correction of finding] are consistent with a defect in glucose transport and/or phosphorylation. In the present study comprising 29 NIDDM patients and 25 matched controls, we tested the hypothesis that HKII activity and gene expression are impaired in vastus lateralis muscle of NIDDM patients when examined in the fasting state. HKII activity in a supernatant of muscle extract accounted for 28 +/- 5% in NIDDM patients and 40 +/- 5% in controls (P = 0.08) of total muscle HK activity when measured at a glucose media of 0.11 mmol/liter and 31 +/- 4 and 47 +/- 7% (P = 0.02) when measured at 0.11 mmol/liter of glucose. HKII mRNA, HKII immunoreactive protein level, and HKII activity were significantly decreased in NIDDM patients (P < 0.0001, P = 0.03, and P = 0.02, respectively) together with significantly decreased glycogen synthase mRNA level and total glycogen synthase activity (P = 0.02 and P = 0.02, respectively). In the entire study population HKII activity estimated at 0.11 and 11.0 mM glucose was inversely correlated with fasting plasma glucose concentrations (r = -0.45, P = 0.004; r = -0.54, P < 0.0001, respectively) and fasting plasma nonesterified fatty acid concentrations (r = -0.46, P = 0.003; r = -0.37, P = 0.02, respectively). In conclusion, NIDDM patients are characterized by a reduced activity and a reduced gene expression of HKII in muscle which may be secondary to the metabolic peturbations. HKII contributes with about one-third of total HK activity in a supernatant of human vastus lateralis muscle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle
Dent, P., Lavoinne, A., Nakielny, S., Caudwell, F. B., Watt, P., & Cohen, P. (1990) · Nature · doi:10.1038/348302a0 · Cited by 519
Yki-Järvinen, H., Sahlin, K., Ren, J. M., & Koivisto, V. A. (1990) · Diabetes · doi:10.2337/diab.39.2.157 · Cited by 131
Eriksson, J., Koranyi, L., Bourey, R., Schalin-J�ntti, C., Wid�n, E., Mueckler, M., Permutt, A. M., & Groop, L. C. (1992) · Diabetologia · doi:10.1007/bf00402546 · Cited by 122
Vestergaard, H., Lund, S., Larsen, F. S., Bjerrum, O. J., & Pedersen, O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116466 · Cited by 98
Self-citationImpaired Expression of Glycogen Synthase mRNA in Skeletal Muscle of NIDDM Patients
Vestergaard, H., Bjørbæk, C., Andersen, P. H., Bak, J. F., & Pedersen, O. (1991) · Diabetes · doi:10.2337/diab.40.12.1740 · Cited by 64
Self-citationBjørbæk, C., Vik, T. A., Echwald, S. M., Yang, P.-Y., Vestergaard, H., Wang, J. P., Webb, G. C., Richmond, K., Hansen, T., Erikson, R. L., et al. (1995) · Diabetes · doi:10.2337/diab.44.1.90 · Cited by 59
Self-citationHuman Hexokinase II mRNA and Gene Structure
Printz, R. L., Ardehali, H., Koch, S., & Granner, D. K. (1995) · Diabetes · doi:10.2337/diab.44.3.290 · Cited by 50
Self-citationAn electrophoretic study of the distribution and properties of human hexokinases
Rogers, P. A., Fisher, R. A., & Harris, H. (1975) · Biochemical Genetics · doi:10.1007/bf00484416 · Cited by 44
Echwald, S. M., Bjørbaek, C., Hansen, T., Clausen, J. O., Vestergaard, H., Zierath, J. R., Printz, R. L., Granner, D. K., & Pedersen, O. (1995) · Diabetes · doi:10.2337/diab.44.3.347 · Cited by 34
Self-citation
Cited by
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Simoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441
Insulin action and insulin resistance in human skeletal muscle
Zierath, J. R., Krook, A., & Wallberg-Henriksson, H. (2000) · Diabetologia · doi:10.1007/s001250051457 · Cited by 367
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Bouché, C., Serdy, S., Kahn, C. R., & Goldfine, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0026 · Cited by 346
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
Ducluzeau, P.-H., Perretti, N., Laville, M., Andreelli, F., Vega, N., Riou, J.-P., & Vidal, H. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1134 · Cited by 263
Yechoor, V. K., Patti, M.-E., Saccone, R., & Kahn, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142301999 · Cited by 156
The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance
Pagel-Langenickel, I., Bao, J., Pang, L., & Sack, M. N. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0003 · Cited by 154
Vind, B. F., Pehmøller, C., Treebak, J. T., Birk, J. B., Hey-Mogensen, M., Beck-Nielsen, H., Zierath, J. R., Wojtaszewski, J. F. P., & Højlund, K. (2011) · Diabetologia · doi:10.1007/s00125-010-1924-4 · Cited by 129
“Consistent with several studies, we also observed defects in insulin activation and phosphorylation of glycogen synthase [15– 17, 24, 43], and lower hexokinase II protein content [44] in type 2 diabetic patients.”
BackgroundResultOsawa, H., Sutherland, C., Robey, R. B., Printz, R. L., & Granner, D. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16690 · Cited by 126
Self-citationInsulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass, M., Koval, J., Vogt, C., Yki-Jarvinen, H., Iozzo, P., Pipek, R., Ardehali, H., Printz, R., Granner, D., DeFronzo, R. A., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.3.387 · Cited by 119
Self-citationØrtenblad, N., Mogensen, M., Petersen, I., Højlund, K., Levin, K., Sahlin, K., Beck-Nielsen, H., & Gaster, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.001 · Cited by 101
“[17].”
Pendergrass, M., Bertoldo, A., Bonadonna, R., Nucci, G., Mandarino, L., Cobelli, C., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2005 · Cited by 87
“Although this could explain, in part, the decrease in insulin-stimulated hexokinase II activity in T2DM and obesity, it cannot explain the markedly reduced ability of insulin to increase muscle hexokinase mRNA levels and protein content reported by us (48, 64) and others (37, 40, 63).”
BackgroundResultInfluentialPratipanawatr, T., Cusi, K., Ngo, P., Pratipanawatr, W., Mandarino, L. J., & DeFronzo, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.462 · Cited by 61
“We (48) and others (70,71) have also shown that a 4-h insulin infusion, although maintaining euglycemia, increases HKII mRNA in skeletal muscle from healthy nondiabetic subjects.”
BackgroundAndreelli, F., Laville, M., Ducluzeau, P.-H., Vega, N., Vallier, P., Khalfallah, Y., Riou, J.-P., & Vidal, H. (1999) · Diabetologia · doi:10.1007/s001250051163 · Cited by 60
“cose transporter (Glut 4) is reduced in adipose tissue [6], whereas the mRNA expression of the glycogen synthase [7] or hexokinase II [ 8 ] is altered in skeletal muscle of insulin-resistant diabetic patients.”
BackgroundInfluential
Metadata
- Authors
- Vestergaard, H., Bjørbaek, C., Hansen, T., Larsen, F. S., Granner, D. K., & Pedersen, O.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-12-01
- Volume
- 96
- Issue
- 6
- Pages
- 2639-2645
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1974952325
- Cited by
- 96
- References
- 10
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.